Your browser doesn't support javascript.
loading
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database.
Fusaroli, Michele; Isgrò, Valentina; Cutroneo, Paola Maria; Ferrajolo, Carmen; Cirillo, Valentina; Del Bufalo, Francesca; Raschi, Emanuel; Poluzzi, Elisabetta; Trifirò, Gianluca.
Afiliação
  • Fusaroli M; Department of Medical and Surgical Sciences, Pharmacology Unit, University of Bologna, via Irnerio 48, Bologna, Italy.
  • Isgrò V; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Cutroneo PM; Sicilian Regional Pharmacovigilance Centre, University Hospital of Messina, Messina, Italy.
  • Ferrajolo C; Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy.
  • Cirillo V; Department of Pediatric Hematology/Oncology, Cellular and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Del Bufalo F; Department of Pediatric Hematology/Oncology, Cellular and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Raschi E; Department of Medical and Surgical Sciences, Pharmacology Unit, University of Bologna, via Irnerio 48, Bologna, Italy.
  • Poluzzi E; Department of Medical and Surgical Sciences, Pharmacology Unit, University of Bologna, via Irnerio 48, Bologna, Italy. elisabetta.poluzzi@unibo.it.
  • Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Drug Saf ; 45(8): 891-908, 2022 08.
Article em En | MEDLINE | ID: mdl-35829913

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Sistemas de Notificação de Reações Adversas a Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Sistemas de Notificação de Reações Adversas a Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2022 Tipo de documento: Article